RE: reckless coverage by Dundee
Sniper...
not much we can do besides encourage the company to do more to educate analysts. Unfortunately the recent past has jaded guys like David Dean and David Martin and now they just cant see the forest for the trees. We need new blood. I know management and IR are working aggressively in this regard. Fundamentally, the fact that there's a bunch of major ( public ) initiatives coming down, especially PRDT / MacoPharma, is giving the company higher profile and attracting the interest of bigger institutions.
We also have to get past the victim mentality and be a little patient. Things are getting executed, communication is better and fundamentals are improving continuously. This is not the same company that it was 2 years ago.... we have to change too.